Student Name
Chamberlain University
NR-326: Mental Health Nursing
Prof. Name:
Date
Risperidone is primarily used to treat psychiatric conditions that involve disturbed thoughts, mood, or behavior. Its top three clinical applications include:
This stimulant is commonly prescribed for:
Lithium is effective in stabilizing mood and is indicated for:
Used across various neurologic and psychiatric contexts, its main indications include:
Methadone’s uses are both therapeutic and supportive, including:
Risperidone acts by antagonizing central dopamine (D2) and serotonin (5-HT2) receptors, which leads to reduced psychotic symptoms and mood stabilization.
This drug enhances central and respiratory nervous system stimulation and has weak sympathomimetic effects, increasing alertness and attention span.
Lithium modulates ion transport in neurons and influences neurotransmitter reuptake, helping to stabilize mood over time.
Increases the concentration of GABA, an inhibitory neurotransmitter, helping to control seizures and mood fluctuations.
Methadone is a synthetic opioid agonist that binds to mu-opioid receptors in the CNS, altering pain perception and producing sedation.
Medication | Common Side Effects | Serious Adverse Reactions |
---|---|---|
Risperidone | Dizziness, dry mouth, constipation, nausea | Neuroleptic malignant syndrome, suicidal ideation, agranulocytosis |
Methylphenidate | Anxiety, insomnia, decreased appetite, tremors | Sudden death, rhabdomyolysis, anaphylaxis |
Lithium | Tremors, nausea, mild diarrhea | Seizures, ECG changes, arrhythmias |
Divalproex Sodium | Dizziness, sedation, gastrointestinal discomfort | Suicidal thoughts, hepatotoxicity, pancreatitis |
Methadone | Drowsiness, headache, nausea | Respiratory depression, QT prolongation, hypotension |
Medication | Route & Dosage (Adults) |
---|---|
Risperidone | PO: 1–8 mg/day (titrated); IM: 25–50 mg every 2 weeks |
Methylphenidate | PO: 5–20 mg 2–3 times/day; Max: 60 mg/day for narcolepsy |
Lithium | PO: Initially 300–600 mg TID; Maintenance: 300 mg 3–4 times/day |
Divalproex Sodium | PO: Start at 10–15 mg/kg/day in divided doses; increase by 5–10 mg/kg/week |
Methadone | PO: 2.5 mg every 8–12 hrs; IM/IV/SubQ: 10 mg every 6–8 hrs |
Medication | Key Patient Education Points |
---|---|
Risperidone | Take as prescribed; report involuntary movements; rise slowly from sitting or lying positions. |
Methylphenidate | Do not double doses; monitor weight; avoid caffeine. |
Lithium | Take consistently; monitor fluid and salt intake; be aware of toxicity symptoms. |
Divalproex Sodium | Take missed doses promptly; avoid driving if drowsy; inform HCP of all concurrent medications. |
Methadone | Avoid alcohol and CNS depressants; don’t drive until effects are known; rise slowly to avoid dizziness. |
Medication | Key Pharmacological Properties |
---|---|
Risperidone | Pregnancy category C; Half-life: 3 hrs (extensive metabolizers), 20 hrs (poor metabolizers) |
Methylphenidate | Schedule II drug; Peak: 1–3 hrs; Short half-life |
Lithium | Pregnancy category D; Half-life: 20–27 hrs; Therapeutic levels: 0.5–1.5 mEq/L (acute), 0.6–1.2 mEq/L (maintenance) |
Divalproex Sodium | Pregnancy category D; Half-life: 9–16 hrs; Therapeutic level: 50–100 mcg/mL |
Methadone | Onset: 30–60 min; Peak: 90–120 min; Half-life: 15–25 hrs; caution in structural heart disease |
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2019). Davis’s Drug Guide for Nurses. Philadelphia, PA: F.A. Davis Company.
Post Categories
Tags